The use of monoclonal antibodies and lectins to identify changes in viral glycoproteins that are influenced by glycosylation: the case of human respiratory syncytial virus attachment (G) glycoprotein
- PMID: 17502674
- DOI: 10.1007/978-1-59745-393-6_8
The use of monoclonal antibodies and lectins to identify changes in viral glycoproteins that are influenced by glycosylation: the case of human respiratory syncytial virus attachment (G) glycoprotein
Abstract
The influence of viral envelope glycans is often overlooked, but one should bear in mind that variable glycosylation may affect the properties of viral envelope glycoproteins and potentially alter the course of an infection. Hence, there is a need for simple methods that can be use to identify changes in the glycosylation pattern of viral glycoproteins in a large number of samples. We describe here methods for the analysis of cell-line specific changes in glycosylation of the respiratory syncytial virus (RSV) attachment glycoprotein (G), which involve the use of lectins and anti-carbohydrate antibodies. Given the role of the G glycoprotein in RSV antigenicity, we also describe procedures based on Western blotting to determine the effect of G protein glycosylation changes on reactivity with human sera. We found that glycosylation of the C-terminal domain of the G protein reduces reactivity with human sera, indicating that variable glycosylation may contribute to evasion of the humoral immune response by RSV.
Similar articles
-
Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein.Virology. 1996 Jul 15;221(2):301-9. doi: 10.1006/viro.1996.0379. Virology. 1996. PMID: 8661440
-
Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.J Med Virol. 2000 Apr;60(4):468-74. J Med Virol. 2000. PMID: 10686032
-
The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.J Gen Virol. 1991 Mar;72 ( Pt 3):669-75. doi: 10.1099/0022-1317-72-3-669. J Gen Virol. 1991. PMID: 2005433
-
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
-
Viruses and glycosylation: an overview.Methods Mol Biol. 2007;379:1-13. doi: 10.1007/978-1-59745-393-6_1. Methods Mol Biol. 2007. PMID: 17502667 Review.
Cited by
-
Immune evasion during foot-and-mouth disease virus infection of swine.Immunol Rev. 2008 Oct;225(1):85-95. doi: 10.1111/j.1600-065X.2008.00672.x. Immunol Rev. 2008. PMID: 18837777 Free PMC article. Review.
-
Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments.Front Immunol. 2024 Mar 1;15:1292588. doi: 10.3389/fimmu.2024.1292588. eCollection 2024. Front Immunol. 2024. PMID: 38495885 Free PMC article. Review.
-
Addicted to sugar: roles of glycans in the order Mononegavirales.Glycobiology. 2019 Jan 1;29(1):2-21. doi: 10.1093/glycob/cwy053. Glycobiology. 2019. PMID: 29878112 Free PMC article.
-
Therapeutic targeting of respiratory syncytial virus G-protein.Immunotherapy. 2010 Sep;2(5):655-61. doi: 10.2217/imt.10.53. Immunotherapy. 2010. PMID: 20874649 Free PMC article. Review.
-
The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.PLoS Pathog. 2021 Apr 8;17(4):e1009469. doi: 10.1371/journal.ppat.1009469. eCollection 2021 Apr. PLoS Pathog. 2021. PMID: 33831114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources